These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15737809)

  • 61. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 62. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine.
    Hurley LP; Harpaz R; Daley MF; Crane LA; Beaty BL; Barrow J; Babbel C; Marin M; Steiner JF; Davidson A; Dickinson LM; Kempe A
    J Infect Dis; 2008 Mar; 197 Suppl 2():S216-23. PubMed ID: 18419400
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies. The Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
    Merkies IS; Schmitz PI; van der Meché FG; van Doorn PA
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):669-71. PubMed ID: 10766905
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rydel-Seiffer fork revisited: Beyond a simple case of black and white.
    Panosyan FB; Mountain JM; Reilly MM; Shy ME; Herrmann DN
    Neurology; 2016 Aug; 87(7):738-40. PubMed ID: 27412138
    [No Abstract]   [Full Text] [Related]  

  • 67. The at-risk foot concerns not only patients with diabetes mellitus.
    Pataky Z; Herrmann FR; Regat D; Vuagnat H
    Gerontology; 2008; 54(6):349-53. PubMed ID: 18446046
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Herpes zoster and postherpetic neuralgia: diagnosis and therapeutic considerations.
    Roxas M
    Altern Med Rev; 2006 Jun; 11(2):102-13. PubMed ID: 16813460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir.
    Quan D; Hammack BN; Kittelson J; Gilden DH
    Arch Neurol; 2006 Jul; 63(7):940-2. PubMed ID: 16682531
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aging and quantitative sensory thresholds.
    Merchut MP; Toleikis SC
    Electromyogr Clin Neurophysiol; 1990; 30(5):293-7. PubMed ID: 2226273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Zoster-associated pain: what is known, who is at risk and how can it be managed?
    Johnson RW
    Herpes; 2007 Sep; 14 Suppl 2():30-4. PubMed ID: 17939893
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reactivation of herpes zoster (shingles) infection associated with an increased risk of death in immunocompetent older persons.
    DeLaGarza VW; Arbogast JG; Podolinski CF; Gunel E
    W V Med J; 2008; 104(5):22-4. PubMed ID: 18846755
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment of herpes zoster and postherpetic neuralgia].
    Schulzeck S; Gleim M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Oct; 44(10):644-50; quiz 651. PubMed ID: 19834828
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
    Burke MS
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical and epidemiological aspects of herpes zoster].
    Vujacich C; Poggi E; Cecchini D; Luchetti P; Stamboulian D
    Medicina (B Aires); 2008; 68(2):125-8. PubMed ID: 18499960
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The assessment of vibration sense in the musculoskeletal examination: Moving towards a valid and reliable quantitative approach to vibration testing in clinical practice.
    O' Conaire E; Rushton A; Wright C
    Man Ther; 2011 Jun; 16(3):296-300. PubMed ID: 21339080
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of pulsed radiofrequency for postherpetic neuralgia.
    Kim YH; Lee CJ; Lee SC; Huh J; Nahm FS; Kim HZ; Lee MK
    Acta Anaesthesiol Scand; 2008 Sep; 52(8):1140-3. PubMed ID: 18840116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The burden of herpes zoster and postherpetic neuralgia in the United States.
    Weaver BA
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Herpes zoster: epidemiology, natural history, and common complications.
    Weinberg JM
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S130-5. PubMed ID: 18021864
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Normative values of vibratory perception in 530 children, juveniles and adults aged 3-79 years.
    Hilz MJ; Axelrod FB; Hermann K; Haertl U; Duetsch M; Neundörfer B
    J Neurol Sci; 1998 Aug; 159(2):219-25. PubMed ID: 9741411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.